A New Clinical Study to Improve the Treatment of Leprosy and Prevent its Harmful Side Effects
- Côte d'Ivoire, Benin, Madagascar Country
- 866.743,70 € Investment
- 2022-26 Length
The Challenge
Hansen’s disease, also known as leprosy, is a chronic infectious Neglected Tropical Disease which can, in addition – if not treated correctly – lead to a series of disabilities and can result in rejection and stigma for sufferers.
Currently, the treatment available for one of the most common complications – erythema nodosum leprosum (ENL) – can lead to serious long-term side effects and is of limited effectiveness. The main goal of this project, therefore, is precisely to improve the treatment.
The solution
To do so, a clinical trial will be conducted together with Medicines Development for Global Health (MDGH) and the Raoul Follereau Foundation.
It will be carried out in a number of research centres in various countries and its aim will be to assess the effectiveness and safety of an innovative treatment for ENL called CC-11050. If the study proves successful, it will improve the protocol for dealing with these cases of leprosy.
Impact
Via this study, we will enhance capacity-building, strengthen active integrated case detection, as well as enable early detection and accurate diagnoses. It will also have an indirect impact on the healthcare system and community healthcare networks.
Related projects
See other projects where we fight Neglected Tropical Diseases
A clinical trial to reduce the treatment time for the Buruli ulcer by half
After decades combatting the Buruli ulcer, which affects thousands of people in over 33 countries, we are still unaware of its exact mode of transmission. We know it is related to environments with stagnant and unsafe water.
Strengthening the African network of laboratories for Buruli ulcer research
There are currently no unified protocols for detecting Buruli ulcer. Although the WHO sets guidelines for the control of NTDs, many laboratories in Africa do not have standardised protocols for sample collection and subsequent screening and diagnosis of these diseases.
Simultaneous diagnosis of five skin-related neglected tropical diseases (skin NTDs)
Through this initiative, we are contributing to strengthening public health systems, from small aid stations in the remotest villages to health centres in reference-point towns.
A New Early Detection System for Buruli Ulcer
This will increase early detection, reducing the number of severe cases of the disease, and in turn will lower expenses for patients and their families as there will be fewer severe cases requiring intensive care.
Better Mental Health for People with NTDs in Nigeria as a Result of Integrated Care
This initiative will support the Nigerian government and other civil society organisations to develop and pilot-test a comprehensive intervention to integrate mental health and NTDs.
An Initiative to Find Innovative Interventions for the Comprehensive Treatment of NTDs
These lessons learnt in Liberia can also be applied to other settings in the region, thereby contributing to a regional exchange of scientific knowledge. Finally, the findings could also be adopted into public health policies in Liberia.
Support for Leprosy Research Teams Via the Leprosy Research Initiative (LRI)
These lessons learnt in Liberia can also be applied to other settings in the region, thereby contributing to a regional exchange of scientific knowledge. Finally, the findings could also be adopted into public health policies in Liberia.
Creating Scientific Research Opportunities on NTDs for Young Professionals from Countries Where these Diseases Are Endemic
Encouraging young researchers in countries where skin NTDs are endemic will contribute to the development of a new generation of scientists who will be better able to understand and manage the challenges of these diseases.
Reducing Stigma and Disabilities
Via this research project we seek to guarantee the Right to Health of people with disabilities, with a special focus on those with NTDs in Côte d’Ivoire and Benin.
